Rystiggo 50474-0980-79
Generic: Rozanolixizumab
- Manufacturer
- Ucb, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 26, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761286
Need to source Rystiggo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rozanolixizumab | 140 mg/mL |
Drug Class
Neonatal Fc Receptor Blocker [EPC]Neonatal Fc Receptor Blocker [EPC]Neonatal Fc Receptor Blockers [MoA]
Selected Package
50474-0980-79Selected1 VIAL, GLASS in 1 CARTON (50474-980-79) / 2 mL in 1 VIAL, GLASS